This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Insulin-like growth factor II
DrugBank Accession Number
DB14472
Background

The insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth regulation, insulin-like and mitogenic activities. To perform its biological activities, this growth factor can present some dependence to somatotropin. It is believed to be a major fetal growth factor in contrast to insulin-like growth factor I, which is a major growth factor in adults.

Type
Biotech
Groups
Experimental
Synonyms
  • CG-IGF2
  • Human insulin-like growth factor II
  • Human oligopeptide-24
  • IGF-2
  • IGF-II
  • Insulin-like growth factor 2
  • Insulin-like growth factor II (human)
  • Insulin-like growth factor-2
  • Insulin-like growth factor-II
  • Multiplication-stimulating activity III-2
  • RH-oligopeptide-8
  • RH-polypeptide-31
  • SH-polypeptide-31

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
HUCORD HSCM-100 AmpouleLiquid0.0000633 g/100mLTopicalHucord Co., Ltd.2015-12-29Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
HUCORD HSCM-100 AmpouleInsulin-like growth factor II (0.0000633 g/100mL)LiquidTopicalHucord Co., Ltd.2015-12-29Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
95067D43FQ
CAS number
67763-97-7

References

General References
Not Available
RxNav
1728770
Wikipedia
Insulin-like_growth_factor_2

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LiquidTopical0.0000633 g/100mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 22:30 / Updated at October 04, 2020 11:46